Off‐label use of PAH‐targeted medications approved for adults and their financial coverage by health insurances are vital for children with pulmonary hypertension
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
---|---|
Enthalten in: |
European Journal of Clinical Investigation - 51(2021), 8 |
Beteiligte Personen: |
Hansmann, Georg [VerfasserIn] |
---|
BKL: |
---|
Anmerkungen: |
Copyright © 2021 Stichting European Society for Clinical Investigation Journal Foundation |
---|
Umfang: |
7 |
---|
doi: |
10.1111/eci.13571 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
WLY004776100 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | WLY004776100 | ||
003 | DE-627 | ||
005 | 20230307141322.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230214s2021 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1111/eci.13571 |2 doi | |
028 | 5 | 2 | |a ECI_ECI13571.xml |
035 | |a (DE-627)WLY004776100 | ||
035 | |a (WILEY)ECI13571 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.03 |2 bkl | ||
100 | 1 | |a Hansmann, Georg |e verfasserin |4 aut | |
245 | 1 | 0 | |a Off‐label use of PAH‐targeted medications approved for adults and their financial coverage by health insurances are vital for children with pulmonary hypertension |
264 | 1 | |c 2021 | |
300 | |a 7 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Copyright © 2021 Stichting European Society for Clinical Investigation Journal Foundation | ||
700 | 1 | |a Christou, Helen |4 aut | |
700 | 1 | |a Koestenberger, Martin |4 aut | |
700 | 1 | |a Sallmon, Hannes |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European Journal of Clinical Investigation |g 51(2021), 8 |w (DE-627)WLY004771389 |x 13652362 |7 nnns |
773 | 1 | 8 | |g volume:51 |g year:2021 |g number:8 |g extent:7 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_WLY | ||
936 | b | k | |a 44.03 |q ASE |
951 | |a AR | ||
952 | |d 51 |j 2021 |e 8 |g 7 |